Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 27,265 $ 62,937
Restricted cash 43 185
Accounts receivable, net of allowance of $462 and $309 as of September 30, 2022 and December 31, 2021, respectively 42,195 57,980
Inventory 15,621 17,217
Prepaid expenses and other current assets 17,262 18,833
Total current assets 102,386 157,152
Property, plant and equipment, net 7,301 7,741
Goodwill 13,641 13,641
Intangible assets, net 5,586 6,438
Right-of-use assets, net 6,066 6,585
Other non-current assets 3,387 3,942
Total assets 138,367 195,499
Current liabilities:    
Accounts payable 25,814 29,709
Deferred revenue 3,553 2,902
Accrued expenses and other current liabilities 34,465 26,967
Senior term loan, current portion 40,791 3,187
Subordinated debt 10,981 10,577
Subordinated term loan – related party 40,607
Convertible debt 43,258
Current portion of long-term debt 242 275
Total current liabilities 199,711 73,617
Subordinated term loan - related party 37,991
Senior term loan 37,876
Convertible debt 41,343
Other long-term liabilities 9,651 20,924
Total liabilities 209,362 211,751
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 73,393,907 and 72,335,952 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 7 7
Additional paid-in capital 768,918 749,592
Accumulated deficit (839,920) (765,851)
Total stockholders’ deficit (70,995) (16,252)
Total liabilities and stockholders’ deficit $ 138,367 $ 195,499